At a glance
ClinicalIndex Comparison RecordN/ACompleted· 13 enrolled
Drug / intervention
Optical Coherence Tomography (OCT)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Optical Coherence Tomography for Microvascular Lung Vessels Obstructive Thromboinflammatory Syndrome Assessment in Patients With COVID-19: an Exploratory Study
In Brief
A clinical study evaluating Optical Coherence Tomography (OCT) for Covid19 and Pulmonary Embolism. Completed, enrolled 13 participants across 2 sites in 2 countries.
Detailed Summary
To evaluate by intravascular OCT study the presence of microvascular pulmonary thrombosis in patients with COVID-19, high D-dimer levels and contrast CT scan negative for pulmonary thrombosis. We'll also evaluate the extension of microvascular pulmonary thrombosis in patients with contrast CT scan positive for pulmonary embolism in areas where contrast CT scan was negative.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19, Pulmonary Embolism
CountriesBrazil, Italy
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedJun 2020
Enrollment StartJun 2020
Primary CompletionSep 2021
TodayJul 2026
First PostedJun 1, 2020
Enrollment StartJun 1, 2020
Primary CompletionSep 30, 2021
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 6.1 years ago
Interventions
Optical Coherence Tomography (OCT)other
To perform OCT in pulmonary artery of patient with COVID-19